Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders

[1]  M. Preece,et al.  Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome. , 2006, The Journal of clinical endocrinology and metabolism.

[2]  M. Preece,et al.  Pharmacokinetic Studies Of Rhigf-I/Rhigfbp-3 Complex Administered To Patients With Growth Hormone Insensitivity Syndrome , 2006 .

[3]  G. Morcaldi,et al.  Heterozygous mutations of growth hormone receptor gene in children with idiopathic short stature. , 2005, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[4]  L. Metherell,et al.  Diagnostic and therapeutic advances in growth hormone insensitivity. , 2005, Endocrinology and metabolism clinics of North America.

[5]  Michael W Parker,et al.  Model for growth hormone receptor activation based on subunit rotation within a receptor dimer , 2005, Nature Structural &Molecular Biology.

[6]  B. Little,et al.  Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. , 2005, The Journal of clinical endocrinology and metabolism.

[7]  M. Rubinstein,et al.  Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: relationship between defects and ethnic groups. , 2004, The Israel Medical Association journal : IMAJ.

[8]  D. Dunger,et al.  Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[9]  S. Gallati,et al.  Primary GH insensitivity '(Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I. , 2004, European journal of endocrinology.

[10]  L. Metherell,et al.  Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction. , 2004, The Journal of clinical endocrinology and metabolism.

[11]  Z. Laron,et al.  Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. , 2004, The Journal of clinical endocrinology and metabolism.

[12]  J. Heinrich,et al.  Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene. , 2004, The New England journal of medicine.

[13]  K. Albertsson-Wikland,et al.  Standard and low‐dose IGF‐I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature , 2004, Clinical endocrinology.

[14]  B. Mendonca,et al.  The first homozygous mutation (S226I) in the highly‐conserved WSXWS‐like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration , 2004, Clinical endocrinology.

[15]  J. Guevara-Aguirre,et al.  Reproducibility in Patterns of IGF Generation with Special Reference to Idiopathic Short Stature , 2003, Hormone Research in Paediatrics.

[16]  Yu-wei Jin,et al.  A Novel Mutation of the Growth Hormone Receptor Gene (GHR) in a Chinese Girl with Laron Syndrome , 2003, Journal of pediatric endocrinology & metabolism : JPEM.

[17]  B. Little,et al.  Growth hormone insensitivity associated with a STAT5b mutation. , 2003, The New England journal of medicine.

[18]  Z. Laron,et al.  Identification of two novel mutations in the human growth hormone receptor gene , 2003, Journal of endocrinological investigation.

[19]  J. Pantel,et al.  Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform. , 2003, The Journal of clinical endocrinology and metabolism.

[20]  P. Clayton,et al.  GH and epidermal growth factor signaling in normal and Laron syndrome fibroblasts. , 2002, Endocrinology.

[21]  M. Preece,et al.  Clinical and Endocrine Characteristics in Atypical and Classical Growth Hormone Insensitivity Syndrome , 2001, Hormone Research in Paediatrics.

[22]  M. Caulfield,et al.  Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity. , 2001, American journal of human genetics.

[23]  C. Pignata,et al.  Abnormal GH receptor signaling in children with idiopathic short stature. , 2001, The Journal of clinical endocrinology and metabolism.

[24]  P. Backeljauw,et al.  Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study. , 2001, The Journal of clinical endocrinology and metabolism.

[25]  U. Francke,et al.  Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity syndrome , 2000, Human mutation.

[26]  H. Luthman,et al.  Characterisation of novel missense mutations in the GH receptor gene causing severe growth retardation. , 2000, European journal of endocrinology.

[27]  M. Tremblay,et al.  Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Waxman,et al.  Pulsatility of growth hormone (GH) signalling in liver cells: role of the JAK-STAT5b pathway in GH action. , 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[29]  M. Preece,et al.  Growth response to rhIGF‐I 80 μg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype , 1999, Clinical endocrinology.

[30]  K. Iida,et al.  The C422F mutation of the growth hormone receptor gene is not responsible for short stature. , 1999, The Journal of clinical endocrinology and metabolism.

[31]  M. Preece,et al.  Long-Term Treatment of Growth Hormone Insensitivity Syndrome with IGF-I , 1999, Hormone Research in Paediatrics.

[32]  P. Saenger.  Partial growth hormone insensitivity ‐ idiopathic short stature is not always idiopathic , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[33]  P. Chatelain,et al.  Treatment of growth hormone insensitivity syndrome with insulin‐like growth factor I: long‐term results of the European multicentre study , 1999 .

[34]  J. Wojcik,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Four Contiguous Amino Acid Substitutions, Identified in Patients with Laron Syndrome, Differently Affect the Binding Affinity and Intracellular Tr , 2022 .

[35]  L. Baumbach,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Growth Hormone Receptor Mutations in Children with , 2022 .

[36]  M. Waters,et al.  A novel mutation affecting the interdomain link region of the growth hormone receptor in a Vietnamese girl, and response to long-term treatment with recombinant human insulin-like growth factor-I and luteinizing hormone-releasing hormone analogue. , 1998, The Journal of clinical endocrinology and metabolism.

[37]  S. Amselem,et al.  Heterozygous mutation in the WSXWS equivalaent motif of the growth hormone receptor in a child with poor response to growth hormone therapy. , 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[38]  K. Iida,et al.  Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain. , 1998, The Journal of clinical endocrinology and metabolism.

[39]  M. Preece,et al.  Phenotype: genotype relationships in growth hormone insensitivity syndrome. , 1997, The Journal of clinical endocrinology and metabolism.

[40]  K. Iida,et al.  Novel compound heterozygous mutations of growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome. , 1997, The Journal of clinical endocrinology and metabolism.

[41]  L. Plotnick,et al.  Partial growth-hormone insensitivity: the role of growth-hormone receptor mutations in idiopathic short stature. , 1997, The Journal of pediatrics.

[42]  N. Niikawa,et al.  The growth hormone receptor gene mutation of a japanese patient with laron syndrome , 1997, Japanese Journal of Human Genetics.

[43]  S. Loche,et al.  A homozygous nonsense mutation of the human growth hormone receptor gene in a Sardinian boy with Laron-type dwarfism , 1997, Journal of endocrinological investigation.

[44]  P. Clayton,et al.  A dominant-negative mutation of the growth hormone receptor causes familial short stature , 1997, Nature Genetics.

[45]  S. Amselem,et al.  Nine novel growth hormone receptor gene mutations in patients with Laron syndrome. , 1997, The Journal of clinical endocrinology and metabolism.

[46]  R. Bartlett,et al.  Clinical, biochemical, and molecular investigations of a genetic isolate of growth hormone insensitivity (Laron's syndrome). , 1997, The Journal of clinical endocrinology and metabolism.

[47]  J. Guevara-Aguirre,et al.  Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency. , 1997, The Journal of clinical endocrinology and metabolism.

[48]  H. Kaji,et al.  No correlation of growth hormone receptor gene mutation P561T with body height. , 1996, European journal of endocrinology.

[49]  A. Clark,et al.  A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. , 1996, The Journal of clinical endocrinology and metabolism.

[50]  L. Groop,et al.  A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency--a clinical research center study. , 1995, The Journal of clinical endocrinology and metabolism.

[51]  T. Clackson,et al.  Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group. , 1995, The New England journal of medicine.

[52]  A. Rundle,et al.  Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. The National Cooperative Growth Study. , 1995, The Journal of pediatrics.

[53]  J. Guevara-Aguirre,et al.  A randomized, double blind, placebo-controlled trial on safety and efficacy of recombinant human insulin-like growth factor-I in children with growth hormone receptor deficiency. , 1995, The Journal of clinical endocrinology and metabolism.

[54]  J. Guevara-Aguirre,et al.  Growth hormone (GH) insensitivity due to primary GH receptor deficiency. , 1994, Endocrine reviews.

[55]  U. Francke,et al.  Receptor mutations and haplotypes in growth hormone receptor deficiency: a global survey and identification of the Ecuadorean E180splice mutation in an oriental Jewish patient , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[56]  M. Preece,et al.  A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH‐binding activity by abolishing receptor homodimerization. , 1994, The EMBO journal.

[57]  M. Preece,et al.  Pharmacokinetics of recombinant human insulin‐like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency , 1993, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[58]  L. Meacham,et al.  Characterization of a noncontiguous gene deletion of the growth hormone receptor in Laron's syndrome. , 1993, The Journal of clinical endocrinology and metabolism.

[59]  U. Francke,et al.  Diverse growth hormone receptor gene mutations in Laron syndrome. , 1993, American journal of human genetics.

[60]  S. Amselem,et al.  SPECTRUM OF GROWTH HORMONE RECEPTOR MUTATIONS AND ASSOCIATED HAPLOTYPES IN LARON SYNDROME , 1993, Pediatric Research.

[61]  Z. Laron,et al.  Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism , 1992, The Lancet.

[62]  L. Underwood,et al.  Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism). , 1991, The New England journal of medicine.

[63]  B. Dallapiccola,et al.  Recurrent nonsense mutations in the growth hormone receptor from patients with Laron dwarfism. , 1991, The Journal of clinical investigation.

[64]  J. Bazan,et al.  Structural design and molecular evolution of a cytokine receptor superfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[65]  G. Novelli,et al.  Laron dwarfism and mutations of the growth hormone-receptor gene. , 1989, The New England journal of medicine.

[66]  L. Meacham,et al.  Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Z. Laron,et al.  EFFECT OF ACUTE ADMINISTRATION OF INSULIN-LIKE GROWTH FACTOR I IN PATIENTS WITH LARON-TYPE DWARFISM , 1988, The Lancet.

[68]  G. Chrousos,et al.  A novel C-terminal growth hormone receptor (GHR) mutation results in impaired GHR-STAT5 but normal STAT-3 signaling. , 2005, The Journal of clinical endocrinology and metabolism.

[69]  L. Metherell,et al.  Novel Growth Hormone Receptor Mutation in a Chinese Patient with Laron Syndrome , 2005, Journal of pediatric endocrinology & metabolism : JPEM.

[70]  Christopher C Lai,et al.  Clinical, Biochemical and Molecular Investigations of Three Taiwanese Children with Laron Syndrome , 2004, Journal of pediatric endocrinology & metabolism : JPEM.

[71]  F. Domínguez,et al.  Novel Mutation Involving the Translation Initiation Codon of the Growth Hormone Receptor Gene (GHR) in a Patient with Laron Syndrome , 2002, Journal of pediatric endocrinology & metabolism : JPEM.

[72]  S. Amselem,et al.  Intronic Mutation in the Growth Hormone (GH) Receptor Gene from a Girl with Laron Syndrome and Extremely High Serum GH Binding Protein: Extended Phenotypic Study in a Very Large Pedigree , 1997, Journal of pediatric endocrinology & metabolism : JPEM.

[73]  M. Preece,et al.  Insulin-like growth factor I improves height in growth hormone insensitivity: two years' results. , 1995, Hormone research.

[74]  P. Rotwein,et al.  Amino acid substitutions in the intracellular part of the growth hormone receptor in a patient with the Laron syndrome. , 1993, The Journal of clinical endocrinology and metabolism.

[75]  U. Francke,et al.  Mutation creating a new splice site in the growth hormone receptor genes of 37 Ecuadorean patients with Laron syndrome , 1992, Human mutation.

[76]  I. Biaggioni,et al.  ドーパミン‐β‐ヒドロキシラーゼ欠乏症における前駆体療法による内因性ノルアドレナリンの回復 , 1987 .